Filed: 11/14/2022ACC: 0001104659-22-118073
📋 What this filing means
ACUTA CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 47 equity positions with a total reported market value of $232.2K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
47
Positions
$232.2K
Total AUM (reported)
13.75M
Total Shares
Allocation by class
COM$178.5K76.9%
COM NEW$27.8K12.0%
COM CL A$14.1K6.1%
PUT$7.4K3.2%
ORDINARY SHARES$2.8K1.2%
COMMON STOCK$1.3K0.6%
SHS$248.000.1%
Portfolio Concentration
Top 3$79.2K34.1%
4–10$64.7K27.9%
11–25$70.9K30.5%
Rest$17.5K7.5%
Top 3 weight
34.1%
Top 10 weight
61.9%
Voting Authority Distribution
Total shares with voting rights: 13.75M
Sole
Full voting authority
13.75M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole47
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings47
Rows:
APELLIS PHARMACEUTICALS INC
SOLEShares554K
TypeSH
Market value$37.8K
16.29%
Sole
554K
Shared
0.00
None
0.00
AADI BIOSCIENCES INC
SOLEShares1.85M
TypeSH
Market value$26.1K
11.25%
Sole
1.85M
Shared
0.00
None
0.00
BELLUS HEALTH INC
SOLEShares1.44M
TypeSH
Market value$15.2K
6.54%
Sole
1.44M
Shared
0.00
None
0.00
RELMADA THERAPEUTICS INC
SOLEShares365.62K
TypeSH
Market value$13.5K
5.83%
Sole
365.62K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares563.61K
TypeSH
Market value$10.1K
4.35%
Sole
563.61K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares272.50K
TypeSH
Market value$9.8K
4.24%
Sole
272.50K
Shared
0.00
None
0.00
BCLS ACQUISITION CORP- CL A
SOLEShares843.12K
TypeSH
Market value$8.4K
3.64%
Sole
843.12K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares324.61K
TypeSH
Market value$7.8K
3.36%
Sole
324.61K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC
SOLEShares267.19K
TypeSH
Market value$7.5K
3.23%
Sole
267.19K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares362.74K
TypeSH
Market value$7.4K
3.20%
Sole
362.74K
Shared
0.00
None
0.00
RELMADA THERAPEUTICS INC
SOLEShares200K
TypeSH
Market value$7.4K
3.19%
Sole
200K
Shared
0.00
None
0.00
KURA ONCOLOGY INC. COMMON STOCK
SOLEShares536.50K
TypeSH
Market value$7.3K
3.16%
Sole
536.50K
Shared
0.00
None
0.00
MIRATI THERAPEUTICS
SOLEShares104.80K
TypeSH
Market value$7.3K
3.15%
Sole
104.80K
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares180K
TypeSH
Market value$6.3K
2.71%
Sole
180K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares27.50K
TypeSH
Market value$5.8K
2.48%
Sole
27.50K
Shared
0.00
None
0.00
JIYA ACQUISITION CORP -CL A
SOLEShares562.50K
TypeSH
Market value$5.6K
2.41%
Sole
562.50K
Shared
0.00
None
0.00
MILESTONE PHARMACEUTICALS IN
SOLEShares597.03K
TypeSH
Market value$5.5K
2.36%
Sole
597.03K
Shared
0.00
None
0.00
SAREPTA TEHRAPEUTICS INC
SOLEShares41.50K
TypeSH
Market value$4.6K
1.98%
Sole
41.50K
Shared
0.00
None
0.00
BIOATLA INC
SOLEShares520K
TypeSH
Market value$4.0K
1.72%
Sole
520K
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares284.50K
TypeSH
Market value$3.4K
1.47%
Sole
284.50K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares290K
TypeSH
Market value$3.0K
1.30%
Sole
290K
Shared
0.00
None
0.00
ARROWHEAD PHARMACEUTICALS INC
SOLEShares87.50K
TypeSH
Market value$2.9K
1.25%
Sole
87.50K
Shared
0.00
None
0.00
GH RESEARCH PLC
SOLEShares243.25K
TypeSH
Market value$2.8K
1.22%
Sole
243.25K
Shared
0.00
None
0.00
ACLARIS THERAPEU
SOLEShares160.84K
TypeSH
Market value$2.5K
1.09%
Sole
160.84K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares303.40K
TypeSH
Market value$2.4K
1.03%
Sole
303.40K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APELLIS PHARMACEUTICALS INCSOLE | COM | 554K | SH | $37.8K 16.29% | 554K | 0.00 | 0.00 |
AADI BIOSCIENCES INCSOLE | COM | 1.85M | SH | $26.1K 11.25% | 1.85M | 0.00 | 0.00 |
BELLUS HEALTH INCSOLE | COM NEW | 1.44M | SH | $15.2K 6.54% | 1.44M | 0.00 | 0.00 |
RELMADA THERAPEUTICS INCSOLE | COM | 365.62K | SH | $13.5K 5.83% | 365.62K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 563.61K | SH | $10.1K 4.35% | 563.61K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 272.50K | SH | $9.8K 4.24% | 272.50K | 0.00 | 0.00 |
BCLS ACQUISITION CORP- CL ASOLE | COM CL A | 843.12K | SH | $8.4K 3.64% | 843.12K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 324.61K | SH | $7.8K 3.36% | 324.61K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INCSOLE | COM NEW | 267.19K | SH | $7.5K 3.23% | 267.19K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 362.74K | SH | $7.4K 3.20% | 362.74K | 0.00 | 0.00 |
RELMADA THERAPEUTICS INCSOLE | PUT | 200K | SH | $7.4K 3.19% | 200K | 0.00 | 0.00 |
KURA ONCOLOGY INC. COMMON STOCKSOLE | COM | 536.50K | SH | $7.3K 3.16% | 536.50K | 0.00 | 0.00 |
MIRATI THERAPEUTICSSOLE | COM | 104.80K | SH | $7.3K 3.15% | 104.80K | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 180K | SH | $6.3K 2.71% | 180K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 27.50K | SH | $5.8K 2.48% | 27.50K | 0.00 | 0.00 |
JIYA ACQUISITION CORP -CL ASOLE | COM CL A | 562.50K | SH | $5.6K 2.41% | 562.50K | 0.00 | 0.00 |
MILESTONE PHARMACEUTICALS INSOLE | COM | 597.03K | SH | $5.5K 2.36% | 597.03K | 0.00 | 0.00 |
SAREPTA TEHRAPEUTICS INCSOLE | COM | 41.50K | SH | $4.6K 1.98% | 41.50K | 0.00 | 0.00 |
BIOATLA INCSOLE | COM | 520K | SH | $4.0K 1.72% | 520K | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 284.50K | SH | $3.4K 1.47% | 284.50K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 290K | SH | $3.0K 1.30% | 290K | 0.00 | 0.00 |
ARROWHEAD PHARMACEUTICALS INCSOLE | COM | 87.50K | SH | $2.9K 1.25% | 87.50K | 0.00 | 0.00 |
GH RESEARCH PLCSOLE | ORDINARY SHARES | 243.25K | SH | $2.8K 1.22% | 243.25K | 0.00 | 0.00 |
ACLARIS THERAPEUSOLE | COM | 160.84K | SH | $2.5K 1.09% | 160.84K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 303.40K | SH | $2.4K 1.03% | 303.40K | 0.00 | 0.00 |
Page 1 of 2